Hello Folks,
I think Q2FY25 is an inflection point for CSTL. The base business volumes are picking up, HALS sales starts to kick-in and monthly run rate is already achieved of 125MT. (On top few other HALS series will start its full swing going forward). From here on, CFCL will enjoy operating leverage and base business will be stable.
Although EBITDA % wise will fall due to HALS ramp-up, but absolute EBITDA will start contributing with meaningful growth.
While no comment on valuation (I feel they are slightly higher), anyone thinks we can take a short-term bet based on “Technicals + Fundamental”.
Views appreciated,
Regards.
Disc: No Holdings.
| Subscribe To Our Free Newsletter |
